U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Drug Recalls
  1. Drug Safety and Availability

Drug Recalls

A drug recall is the most effective way to protect the public from a defective or potentially harmful product. A recall is a voluntary action taken by a company to remove a defective drug product from the market or warn patients and consumers about a potential risk.

The list below includes voluntary drug recalls in which public notification has been issued.

Visit FDA’s role in drug recalls for more information.
Visit Recalls, Market Withdrawals, & Safety Alerts for all FDA-regulated products.
Follow FDA Recall Information on X (formerly Twitter).



Filter by

A Terminated Recall is a recall where the FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard. Recalls that are not indicated as being terminated are either ongoing or completed.

Date Brand Name(s) Product Description Recall Reason Description Company Name Terminated Recall Excerpt
Vitality Vitality male enhancement dietary supplement capsules Undeclared Sildenafil and Tadalafil One Source Nutrition
BD ChloraPrep Clear 1 mL applicator skin preparation product Potential for fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides BD
ICU Medical POTASSIUM CHLORIDE Inj. 20 mEq and 10 mEq Bags of POTASSIUM CHLORIDE Inj. 20 mEq have incorrect overwrap labels which state POTASSIUM CHLORIDE Inj. 10 mEq. ICU Medical
Alvogen Fentanyl Transdermal System 25 mcg/h transdermal patches There is potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch Alvogen, Inc.
Provepharm Inc. Phenylephrine hydrochloride Injection, USP, 10 mg/ mL Device & Drug Safety – Potential Foreign Material Provepharm Inc.
Astellas Tacrolimus and Tacrolimus Extended-Release capsules Bottles may contain empty capsules. Astellas Pharma US, Inc.
Systane Lubricant Eye Drugs Due to Fungal Contamination Alcon Laboratories
Par Pharmaceutical Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP) Product is an unapproved drug. Endo, Inc.
Fouzee SugarLin Herbal Formula Herbal Dietary Supplement Product contains undeclared Metformin and Glyburide Shoppers-Plaza
Force Forever Dietary Supplement Product contains undeclared diclofenac and dexamethasone GNMART Inc
Download XLSX
Back to Top